Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low versus high protamine-to-heparin ratio in CABG surgery with cardiopulmonary bypass
NL-OMON22454Active, not recruiting
- Sponsor
- VU University Medical Center
- Start
- Sep 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of protamine and heparin in coronary arteriosclerosis (2 arms), sponsored by VU University Medical Center. Primary endpoint: Postoperative 24-hour blood loss. Started Sep 2012; status: active, not recruiting.
02
Drugs
protamineheparin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON22454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22454.